Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach

INIS

• diseases 100%
• glucose 100%
• covid-19 100%
• drugs 33%
• proteins 33%
• genes 33%
• regulations 33%
• variations 33%
• genetics 33%
• energy 16%
• production 16%
• data 16%
• transcription factors 16%
• interactions 16%
• laboratories 16%
• molecules 16%
• information 16%
• viruses 16%
• stability 16%
• availability 16%
• resources 16%
• gene loci 16%
• coronaviruses 16%

Biochemistry, Genetics and Molecular Biology

• XIAP 16%
• PARP1 16%
• BECN1 16%
• Toxicogenomics 16%
• STK11 16%